Sitemap - 2022 - The Active Surveillor
'AS 2022 in Review': Active Surveillance in the news
Depression: Prostate cancer diagnosis? Or could it be prostate-shrinking meds?
'The Invasion of the Prostate Snatchers: 13 years Later': An Evening with Dr. Mark Scholz
Time to Rage Against The Prostate Cancer Machine
Gleason 6? Dr. Eggener: It's "wimpy"
Part II: "Physics, bitches." The lowdown on MRIs, gadolinium and more
The persistent mythology of urology: urinary symptoms and most prostate cancers
Have we been getting the straight dope on MRIs? Nope, says myth-busting med physicist
Active surveillance for low-risk prostate cancer: Why can’t America be more like Sweden?
Time's up at high noon Eastern to respond to AS survey
A fork in my 'cancer journey'--colon cancer markers
“Hope I die before I get prostate cancer”-- Who's “My Generation” anthem revised
Mental distress affects many with prostate cancer
Biopsies: Going, going but not totally gone
We have questions on AS. Please share your answers to enlighten our docs and policymakers.
Are 'gremlins' plaguing your PSA levels?
Please complete survey on issues confronting Active Surveillance patients
Debunking myths of urinary symptoms and prostate cancer
The urologist and 'the cheap little Sony'
PLEASE--respond to the AS survey to see where we stand on issues and guide policymakers
48 hours in the belly of the healthcare beast--with "a hot colon"
AS's dirty little secret: The dropout rate
How Active Surveillance programs can reach 90%-plus of low-risk patients
MRI shines a light on whether we need biopsies
PCa patient advocate Mark Lichty's adventures with BPH and TURP
Contrasts in care: Europe finally on board with early detection of prostate cancer
Dr. Nick Vogelzang, top figure in advanced prostate cancer research, dead at 72 from lymphoma
AS 101: Schooling patients in the "gray zone," newbies and even old hands on active surveillance
Prostate cancer passing breast cancer in some countries, while lagging in research/awareness
Active surveillance pioneer calls for end to transrectal biopsies--ASAP.
Is PSMA-PET imaging in the cards for Low-Risk Active Surveillors?
Meetings galore for Prostate Cancer Awareness Month
Moving the Needle on AS. Michigan Shows a Path to a 90%+ AS Rate
Black Men and Active Surveillance. Not Black And White But a Viable Option.
‘Great Biopsy Debate': Is 'Big Urology' ready for biopsy reform? Porsche vs. Honda biopsies?
‘Great Biopsy Debate': Is 'Big Urology' ready for biopsy reform? Porsche vs. Honda biopsies?
Breaking news: Transperineal biopsies beat transrectals in AnCan debate
Attend PCa 'College': Active Surveillance 101 course launches at ASPI meeting on Sept. 24
New validation of blood test that can cut biopsy rates in half for patients with rising PSAs
Micro-ultrasound: The prostate image of the future? Lookin' good, but the jury is still out.
'Mindful surveillance' plan helps Randy Apsel get past anxious response to prostatitis
Predicting PCa prognosis with 'Predict Prostate'
French study offers insight on emotional issues and prostate cancer
The time has come to Increase awareness of emotional health and prostate cancer
Debate over prostate biopsies not over in U.S.
This just in: Can a new MRI technique reduce biopsies by 90%?
Has the time come to address anxious surveillance?
Therapist/cancer survivor explains how to heal anxiety
Dr. William Li presents to ASPI: Of lycopene, tangerine tomatoes, angiogenesis and lots more
This just in at AnCan: The Great Biopsy Debate 2022--transperineal v. transrectal August 29.
Signals from the prostate: Is it smoke? Or fire?
Potent meds future for low-risk patients?
Urologist tells Gilda's Club session about his personal journey with prostate cancer
Stop Ignoring Mental Health in Prostate Cancer Patients
Must-read for potential active surveillors: New edition of ‘The Invasion of the Prostate Snatchers’
Ethics of giving 'em what they want
AS patients: Let’s spit for science in search of genetic clues in prostate cancer
Part II: Different strokes for different AS patients: The case of the two octogenarians
Some good news for plant-based diets in dealing with prostate cancer
Part I: Does age matter with Active Surveillance?
Eat to beat your prostate cancer with TED talker Dr. WIlliam Li
New debate for transperineal biopsies: ¿Despierto o dormido? Awake or asleep?
Will renaming Gleason 6 as a noncancer help?
Tick, tock. Sign up for the AnCan webinar on June 29 on genomics and genetics
The Sleeping Lion and The Snarling Tiger: Our Prostate Cancer Journeys
Between early signs and diagnosis--the next stop: The Twilight Zone
Is robotic prostatectomy bad medicine?
ENACT study shows 'enza' significantly slows progression of low-risk prostate cancer
Chasing Dr. Ryan: Where does AS stand in research priorities of the Prostate Cancer Foundation?
Ask Dr. Ryan on radio show: What does PCF spend on AS research?
MLB swinging for the fences to raise funds for PCF and prostate cancer research
Transgender women with prostate cancer: Get over it.
Join me on Zoom at the Tri-Cities Support Group
Rolling the dice with Active Surveillance
(Part III) Some parting thoughts on 'the perineural invasion'
(Part II) The perineural invaders
(Part I)Perineural invasion: Not so scary
(Part I) Perineural invasion sounds scarier than it is
phi and 4Kscores equals in predicting upgrades to Gleason 7
Of low-risk 'prostate cancer,' diet, donuts and exercise
Tales of Low-Risk Prostate Cancer: 'Louie' avoids an OR rush to unnecessary surgery
What do you get for the Dad who has everything, including prostate cancer?
What should we call Gleason 6 diagnoses if we drop "The Big C"?
Active surveillance hits 60% in the U.S., but lags far behind Canada, Holland, and Sweden
The case of the mysterious prostate operation and the San Diego Padres’ skipper
ASPI honors pioneers: its late medical advisor, Gerald Chodak, MD; Laurence Klotz, MD AS 'father'
Uro-Skeptic Vorstman Sounds Off: 'PSA Testing, Active Surveillance and More Damned Lies'
Prostate cancer? You gotta' be your own advocate
We Don’t Need To Rename Low Grade Prostate Cancer: It’s Not Complicated
Eat, sweat, sleep, learn, prostate cancer
Stirring the Gleason 6 Pot--to Drop the Cancer Label
AS Webinars: Lifestyle, Future of AS, Decisional Regret
The Gleason 6 name game--what to call it?
Reduced prostate cancer screening decreases overdiagnosis but may miss aggressive cases
Did you attend the webinar today on the future of AS?
Breaking news on the debate on whether Gleason 6 is a cancer
New research finds a potential bacterial link to aggressive prostate cancer
Extra, Extra Read All About It: Renaming Gleason 6 as a noncancer
UCSF's Cooperberg calls out underuse of active surveillance
A modest proposal? Relabel Gleason as a noncancer.
IsoPSA cuts biopsy rate in half for newbies
'Eggener 6' tilting at removing the 'cancer' diagnosis from Gleason 6 diagnosis
Time is running out--please register for the webinar on the future of AS on April 22
Almost final call--Join the A(S)-team on the future of Active Surveillance
Apologies. Sorry, Sorry: I typoed the date for webinar on the future of AS. It should be April 22
My best 'pros mitzvah' gift?: Renaming Gleason 6 as noncancerous or precancerous
Is Active Surveillance for low-risk prostate cancer on its way out?
Tick tock. Please register for the summit on the future of active surveillance
When is cancer a 'blessing'? When it's a Gleason 6 'cancer.'
'Decisional regret' and low-risk prostate cancer
Must read: Lies, dirty lies and prostate cancer
Was AS your best choice after all?
AS, an overnight success story? Hardly: early advocate
HOT OFF THE PRESSES: AS reaches new heights in U.S., UCSF’s Cooperberg
Whole Person Care to Better Treat Cancer – Anxiety – Depression (Part II)
Bits and pieces: Follow-ups on trans women with prostates, biopsy-free prostatectomies, and more
Watch your language: It's past time to include women with prostate cancer in our reluctant fold.
Whole Person Care to Better Treat Cancer--Anxiety-Depression (Part I)
Your Voice on the Future of Active Surveillance
Have your voice heard on the future of AS in a free international webinar
Snarling Tiger snatches iconic actor William Hurt
BREAKING NEWS: Worried about a 10 (or above)?
BREAKING NEWS: Worried about a 10 (or above)?
Breaking news: Participate with World Experts in Webinar on the Future of Active Surveillance
Program for Newly Diagnosed Patients at the Prostate Cancer of Orange County on March 8
ASPI webinar on reducing 'anxious surveillance' set for March 26
Join the ZERO Prostate Cancer SUMMIT
This just in: Help vets and prostate cancer researchers
Novel strategies to treat prostate cancer
Part II: The Ugly American (Urologist)?
Come to the ZERO Prostate Cancer SUMMIT
Minority men not represented in online media re prostate cancer, NYU researchers report
Join an Irish study on prostate cancer, please
Still time to sign up for the ASPI event at noon today Eastern
Part I Transrectal biopsies? Avoid them at all costs, Canadian prostate expert tells webinar
Extra! Extra! The Secret Life of the Prostate at noon Eastern this Saturday, Feb. 26.
Some insurance companies are open to covering men with low-risk prostate cancer
Lies, dirty lies, and insurance discrimination
Calendar update--late February into March
AS gaining respect--Rodney Dangerfield no more
A man with a ('mindful' AS) plan
This just in: weigh in on legislation in Illinois to make prostate screening cost-free NOW
Many docs think AS best choice for patients
Dr. Mark Scholz to speak to The Prostate Forum of Orange County Feb. 24 on Zoom
The Secret Life of the Prostate
What happened when you first were diagnosed with prostate cancer?
'Wildcard’: A journey of genetics, waiting, frustration, desperation, and, finally, a big decision
PCa support groups in February
Listen, do you want to know a secret?
Small reader survey finds one in four respondents take metformin, the diabetes med
Calendar update: February into March.
Cancer ABCs Jan Manarite answering questions on prostate cancer on February 2
Prostate protection that comes from the heart
Howard Furer says his diet has helped him
"At 82, I’ve been on AS for 14 years and plan to stay on it."--Howard Furer.
Cancer, Chronic Illness, and Intimacy
Get the lowdown on the differences between prostate cancer care: Canada v. United States
Does metformin prevent prostate cancer? Or increase risk? Or both?
Still time to register for ASPI program on "anxious surveillance"
Do you tell friends and family that you have prostate cancer?
Finding the wolves amidst the sheep
81 and deciding how to proceed as an active surveillance patient
The Active Surveillor Survey respondents with brass cojones speak out
"We've never understood the prostate"
The Active Surveillor Calendar
Overcoming ‘anxious surveillance,’ staying on active surveillance
Good news, bad news for prostate cancer
Active Surveillors: Is there a hurry with treatment?